Quarterly report pursuant to Section 13 or 15(d)

Common Stock and Employee Equity Plans (Tables)

v3.22.2.2
Common Stock and Employee Equity Plans (Tables) - USD ($)
shares in Thousands, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 24, 2022
Sep. 24, 2022
Sep. 25, 2021
Equity [Abstract]      
Schedule of Common Shares Outstanding  
Common Stock
Shares of common stock outstanding were as follows:
Three Months Ended Nine Months Ended
September 24,
2022		 September 25,
2021		 September 24,
2022		 September 25,
2021
(In millions)
Balance, beginning of period 1,612  1,213  1,207  1,211 
Common stock issued in the acquisition of Xilinx —  —  429  — 
Common stock issued under employee equity plans 10  6  14  8 
Common stock repurchases for tax withholding on equity awards (3) —  (5) — 
Issuance of common stock to settle convertible debt —  —  —  3 
Repurchases of common stock (7) (7) (33) (10)
Balance, end of period 1,612  1,212  1,612  1,212 
 
Share-based Payment Arrangement, Expensed and Capitalized, Amount  
Stock-based Compensation
Stock-based compensation expense was recorded in the Condensed Consolidated Statements of Operations as follows: 
Three Months Ended Nine Months Ended
September 24,
2022		 September 25,
2021		 September 24,
2022		 September 25,
2021
(In millions)
Cost of sales $ 8  $ 2  $ 20  $ 4 
Research and development 185  63  478  171 
Marketing, general and administrative 82  34  268  92 
Total stock-based compensation expense before income taxes 275  99  766  267 
Income tax benefit (91) (16) (166) (43)
Total stock-based compensation expense after income taxes $ 184  $ 83  $ 600  $ 224 
 
Stock Repurchased During Period, Shares 6,900 32,800  
Payments for Repurchase of Common Stock   $ 3,452 $ 1,004